Nanobots Therapeutics Analysis

Unique therapeutic entities for targeted drug delivery

Enhance drug delivery to target cells; Improve treatment efficacy for bladder cancer; Develop novel drug modalities for various indications; Facilitate targeted delivery of therapeutic agents; Monitor in vivo behavior of nanomotors.

Spin-off from ICREA and IBEC; Recognized with AECC IMPACTO grant; Closed a €1M seed funding round.

Main Information

• Information: Nanobots Therapeutics is a health-focused, deeptech company developing the MotionTx platform, which enhances drug accumulation in target cells, with its first indication being bladder cancer.
• Interests: HEALTH/FITNESS/WELLBEING
• Location: Hall 8.1 - 4YFN Stand 8.1A40
• Whether tagged as startup: Yes

Contact & Links

• LinkedIn: Not found
• Twitter: Not found
• Phone Number: Not found
• Email: Not found

Key Information

• Growth Stage: Seed
• Country: Spain
• Founding Year: 2023

Company Context

Company Name: Nanobots Therapeutics; Company Website: https://www.nanobotstx.com/